Infectious Disease Research,
Nothing Else
TransPharm Preclinical Solutions performs efficacy testing of novel antimicrobial therapeutics—antibiotics, antivirals, antifungals, and antiparasitics—using validated in vitro assays and in vivo infection models. We are the only CRO that does this exclusively.
Partners & Accreditations
Who We Serve
Built for Teams Bringing Novel Anti-Infectives to Market
Different programs, different pressures. Our work is tailored to the realities, requirements, and constraints of each partner we serve.
Fast, cost-effective, reliable infection models to validate candidates, then move to the next round.
Specialized models, dependable data, and the scientific caliber your regulatory package demands.
Preclinical infection testing for devices, coatings, and combination products suited to rodent models.
BSL-2 infectious disease models you can’t run in-house, delivered with full compliance support.
Who We Are
Our deep specialization is a competitive advantage, for us and for you.
Most CROs cover a broad range of research categories. TransPharm Preclinical Solutions does one thing, and has done it for nearly two decades: antimicrobial drug development. That depth of focus means our scientists aren’t generalists learning your study on the fly—they’re specialists who’ve designed and run hundreds of studies just like yours.
We’ve partnered with pharmaceutical companies large and small, biotech startups, academic medical centers, and government agencies. Our track record is built on flexibility, responsiveness, and data you can trust.
What We Do
Each of our services is built specifically for the development of antimicrobial therapeutics.
From first screens to full efficacy data packages, we cover the complete preclinical workflow.
Murine and rat models for pneumonia, sepsis, thigh, UTI, wound, osteomyelitis, and more. PK/PD and maximum tolerated dose studies also available.
MIC, MBC, time-kill kinetics, checkerboard analyses, and more—performed against our validated pathogen library using CLSI-standard methods.
Hundreds of validated strains—including multidrug-resistant isolates—available on-site. Additional strains sourced on request.
Study reports, regulatory summaries, and manuscript preparation—clear, defensible, and submission-ready.
Why TransPharm Preclinical Solutions
When your compound needs data, you need a partner who knows how to do it all.
We’ve navigated the preclinical process with over 100 clients across the globe—from early-stage biotech companies with a single candidate to major pharmaceutical companies running parallel programs. Every study is customized, and every dataset is defensible.
We start with a call to understand your compound, your endpoints, and your timeline.
Our scientists will design a protocol that’s tailored specifically to your program.
At this step, communication is key. Whatever it is you need, we’ll always be reachable.
Clear, defensible, submission-ready reports written by the scientists who ran your study.
Endorsements
What Our Clients Say
TransPharm gives great dollar value, attention to detail, careful reporting, and a bonus of insight of interpretation and future direction for my studies. Great people to work with. Very timely in communication. Sure benefited my project.
We were very pleased with the professionalism, quality, and value of the work we did with TransPharm Preclinical Solutions. Dan and his team knew exactly what we were looking for, and the program was completed flawlessly and on time. We look forward to working with them again in the future.
Published Data & Research
Work That Holds Up Under Peer Review
Our studies have contributed to peer-reviewed publications, industry presentations, and regulatory data packages. When our clients publish, we often publish with them—because defensible science stands up to scrutiny.